• Return to Headlines

0.6% Return Seen to Date on SmarTrend Myriad Genetics Call (MYGN)

By David Diaz

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on January 15th, 2020 at $29.32. In approximately 3 weeks, Myriad Genetics has returned 0.61% as of today's recent price of $29.50.

In the past 52 weeks, Myriad Genetics share prices have been bracketed by a low of $15.15 and a high of $33.42 and are now at $28.99, 91% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 1.2%.

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, and catch disease at an early stage.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Myriad Genetics shares.

Log in and add Myriad Genetics (MYGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights myriad genetics

Ticker(s): MYGN